Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
275,386,419
-
Share change
-
+2,716,817
-
Total reported value
-
$10,755,340,234
-
Put/Call ratio
-
133%
-
Price per share
-
$39.07
-
Number of holders
-
766
-
Value change
-
+$121,959,688
-
Number of buys
-
373
-
Number of sells
-
321
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q1 2018
As of 31 Mar 2018,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
766 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
275,386,419 shares.
The largest 10 holders included
DODGE & COX, ROYAL BANK OF CANADA, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, STATE STREET CORP, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, BANK OF AMERICA CORP /DE/, and WELLS FARGO & COMPANY/MN.
This page lists
769
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.